Drug Type AAV based gene therapy |
Synonyms Adeno-Associated Virus 9 vector expressing human Metabolism of Cobalamin Associated C gene (NHGRI/NIH) |
Target |
Action agonists |
Mechanism MMACHC agonists(metabolism of cobalamin associated C agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Methylmalonic Acidemia With Homocystinuria | Preclinical | United States | 13 May 2025 | |
| Methylmalonic Acidemia | Preclinical | United States | 09 Oct 2024 |





